Nanocopoeia Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Nanocopoeia

Access the complete profile.

Nanocopoeia Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	1246 University Avenue West Suite 463 St Paul, MN 55104

Note: Revenues for privately held companies are statistical evaluations.


Nanocopoeia's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Nanocopoeia's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Nanocopoeia is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Nanocopoeia Annual Revenue and Growth Rate

Nanocopoeia	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Nanocopoeia's revenues are gauged from an analysis of company filings.

Nanocopoeia's Income Statement (based on Industry Averages)

Nanocopoeia P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Nanocopoeia is developing and marketing. Nanocopoeia doesn't have any recent trademark applications, indicating Nanocopoeia is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PHAMROVY Pharmaceuticals, including protein kinase inhibitors used for the treatment of some leukemias in humans	07/18/2022
PHYRAGO Pharmaceutical preparations, namely, protein kinase inhibitors used for the treatment of some leukemias in humans	07/18/2022
ELECTRONANOSPRAY Research and development of pharmaceutical products for others; development of pharmaceutical drug formulas for others	04/09/2012

See all trademarks and details in the Full Report.

Market Share of Nanocopoeia's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nanocopoeia, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Nanocopoeia. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BELL INTERNATIONAL LABORATORIES	Eagan, MN	100
ZEPTO LIFE TECHNOLOGY	Saint Paul, MN	13
NANOCOPOEIA	St Paul, MN	11
BIOTHERA PHARMACEUTICALS	Mendota Heights, MN	11
CEREBRAL THERAPEUTICS	Oakdale, MN	7
BIOTHERA	Saint Paul, MN	1

Future Competition: Nanocopoeia's Fastest Growing Competitors

These companies are in the same general field as Nanocopoeia and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)